Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $67.9M | Sell |
1,231,009
-4,519
| -0.4% | -$245K | 0.08% | 203 |
|
|
2025
Q4 | $60.6M | Buy |
1,235,528
+60,273
| +5% | +$2.81M | 0.07% | 224 |
|
|
2025
Q3 | $50.7M | Buy |
1,175,255
+81,613
| +7% | +$3.19M | 0.07% | 247 |
|
|
2025
Q2 | $42M | Buy |
1,093,642
+961,577
| +728% | +$36.7M | 0.06% | 266 |
|
|
2025
Q1 | $5.12M | Buy |
132,065
+15,104
| +13% | +$553K | 0.01% | 811 |
|
|
2024
Q4 | $3.96M | Buy |
116,961
+736
| +0.6% | +$26.5K | 0.01% | 883 |
|
|
2024
Q3 | $4.75M | Buy |
116,225
+5,662
| +5% | +$232K | 0.01% | 802 |
|
|
2024
Q2 | $4.26M | Buy |
110,563
+5,828
| +6% | +$245K | 0.01% | 788 |
|
|
2024
Q1 | $4.49M | Sell |
104,735
-8,220
| -7% | -$339K | 0.01% | 776 |
|
|
2023
Q4 | $4.19M | Buy |
112,955
+9,762
| +9% | +$350K | 0.01% | 750 |
|
|
2023
Q3 | $3.74M | Buy |
103,193
+11,169
| +12% | +$396K | 0.01% | 746 |
|
|
2023
Q2 | $3.28M | Sell |
92,024
-5,708
| -6% | -$205K | 0.01% | 799 |
|
|
2023
Q1 | $3.48M | Buy |
97,732
+14,118
| +17% | +$494K | 0.01% | 746 |
|
|
2022
Q4 | $2.94M | Buy |
83,614
+13,322
| +19% | +$444K | 0.01% | 772 |
|
|
2022
Q3 | $2.07M | Buy |
70,292
+4,425
| +7% | +$168K | 0.01% | 759 |
|
|
2022
Q2 | $3.58M | Buy |
65,867
+6,131
| +10% | +$338K | 0.01% | 568 |
|
|
2022
Q1 | $3.25M | Buy |
59,736
+7,581
| +15% | +$412K | 0.01% | 593 |
|
|
2021
Q4 | $2.88M | Buy |
52,155
+10,396
| +25% | +$541K | 0.01% | 564 |
|
|
2021
Q3 | $2M | Buy |
41,759
+6,381
| +18% | +$321K | 0.01% | 539 |
|
|
2021
Q2 | $1.76M | Buy |
35,378
+211
| +0.6% | +$10.1K | 0.01% | 518 |
|
|
2021
Q1 | $1.57M | Sell |
35,167
-1,411
| -4% | -$64K | 0.01% | 507 |
|
|
2020
Q4 | $1.68M | Sell |
36,578
-2,427
| -6% | -$111K | 0.01% | 459 |
|
|
2020
Q3 | $1.83M | Sell |
39,005
-2,905
| -7% | -$146K | 0.02% | 389 |
|
|
2020
Q2 | $2.14M | Buy |
41,910
+5,297
| +14% | +$272K | 0.02% | 368 |
|
|
2020
Q1 | $1.73M | Buy |
36,613
+3,335
| +10% | +$178K | 0.02% | 383 |
|
|
2019
Q4 | $1.96M | Buy |
33,278
+81
| +0.2% | +$4.51K | 0.02% | 397 |
|
|
2019
Q3 | $1.77M | Buy |
33,197
+6,382
| +24% | +$328K | 0.02% | 382 |
|
|
2019
Q2 | $1.34M | Buy |
26,815
+18,245
| +213% | +$916K | 0.02% | 468 |
|
|
2019
Q1 | $448K | Buy |
8,570
+2,776
| +48% | +$139K | 0.01% | 695 |
|
|
2018
Q4 | $277K | Buy |
5,794
+141
| +2% | +$6.94K | ﹤0.01% | 691 |
|
|
2018
Q3 | $284K | Sell |
5,653
-145
| -3% | -$7.37K | 0.01% | 674 |
|
|
2018
Q2 | $292K | Buy |
5,798
+330
| +6% | +$16.6K | 0.01% | 644 |
|
|
2018
Q1 | $267K | Buy |
+5,468
| New | +$255K | 0.01% | 548 |
|
|
2016
Q4 | – | Sell |
-8,647
| Closed | -$468K | – | 659 |
|
|
2016
Q3 | $468K | Buy |
+8,647
| New | +$474K | 0.02% | 380 |
|
|
2014
Q1 | – | Sell |
-4,227
| Closed | -$282K | – | 350 |
|
|
2013
Q4 | $282K | Buy |
4,227
+306
| +8% | +$19.8K | 0.04% | 284 |
|
|
2013
Q3 | $246K | Buy |
3,921
+111
| +3% | +$7.14K | 0.05% | 260 |
|
|
2013
Q2 | $238K | Buy |
+3,810
| New | +$242K | 0.05% | 233 |
|
Other funds holding GSK
JEST
Mariner's GSK Position: Q1 2026 in Review
Mariner reduced its GSK (GSK) stake by 0.37% in Q1 2026, selling an estimated $245K and leaving 1,231,009 shares worth $67.9M. The position accounts for 0.08% of the portfolio, ranked #203.
Mariner first reported a position in GSK in Q2 2013 and has held it in 37 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Mariner held 1,231,009 shares of GSK worth $67.9M as of Q1 2026.
- Mariner sold 4,519 GSK shares in Q1 2026, an estimated $245K.
- GSK made up 0.08% of Mariner's portfolio in Q1 2026, its #203 holding.
- Mariner first reported a position in GSK in Q2 2013 and has held it in 37 quarters since.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.